Lupus Peer-to-Peer Early Education Program Expands
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly...
BMS
LRA Brings Encouraging News from European Rheumatology Meeting
June 2, 2022
The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...
Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive...
Lupus Clinical Trials Redefined: You Make the Difference
Lupus Clinical Trials Redefined: You Make the Difference
Lupus Clinical Trials Virtual Fair
October 17, 2020
10:00 am to 1:00 pm ET
Register...
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
New York, NY– June 27, 2019. The Lupus Research Alliance (LRA) and clinical research affiliate, Lupus Therapeutics, broadened a collaboration...